Extract notice to the Minister

Ran-Meropenem

Common name / Subject : meropenem
Name of the manufacturer : Ranbaxy
Form :
Dosage :

Indication :

INESSS' Recommendation
Inscription

Minister's decisions
Inscrire aux listes des médicaments

Evaluation published on August 18, 2021

Subscribe to our newsletter now

Subscription